The problem is chemistry isn’t that different from software. Once you publish the idea it isn’t too difficult to derive the chemical composition. Replication is

The problem is chemistry isn’t that different from software. Once you publish the idea it isn’t too difficult to derive the chemical composition. Replication is the easy part. Design and testing cost money. So in essence we’d have to design drugs and not publish the chemistry which would be uncovered soon enough anyways. This leads to a situation where investment dollars go into other things and human health suffers, especially with so-called rare diseases. Not to mention the USA loses hegemony. The USA provides Europe with a great deal of military technology and protection as well as medicine but it isn’t for free. The EU exchanges agency in many ways important strategically to American interests. It’s mainly a fair deal.